pharmaphorum

MAY 14, 2021

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. Proxalutamide is not approved or available for sale and the Brazilian study has not been peer-reviewed or published.

Drug Trials 52

Drug Trials Trials Drugs Dermatology 52

XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion in pharmaceutical sales from 2021. Notably, sales from their COVID-19 drug Actemra (tocilizumab) dropped significantly by 22 percent.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Delveinsight

AUGUST 25, 2021

The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms. They both made a sale of USD 3.8 The annual sale of Novartis in the year 2020 was USD 48.6

Vaccination 98

Vaccination Vaccine Sales Drugs 98

The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group. Immune Regulation – U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

AUGUST 1, 2021

The approval by the Food and Drug Administration (FDA) was based on efficacy and safety data from the Saphnelo clinical development programme, including two TULIP Phase III trials and the MUSE Phase II trial. Under the agreement AstraZeneca will pay BMS a low to mid-teens royalty for sales dependent on geography. 7,8,9,10,11.

Trials 52

Trials Clinical Development Antibody Dermatology 52

The Pharma Data

JANUARY 13, 2021

Fast Track designation facilitates the development and expedites the review of drugs that are intended to treat serious and life-threatening conditions and show the potential to fill an unmet medical need. Brilacidin, a versatile compound with broad therapeutic potential, is in a new chemical class called defensin-mimetics.

Clinical Trials 52

Clinical Trials Clinical Trials Trials In-Vitro 52